Literature DB >> 9009106

Assessment of the invasive potential of human gynecological tumor cell lines with the in vitro Boyden chamber assay: influences of the ability of cells to migrate through the filter membrane.

A M Sieuwerts1, J G Klijn, J A Foekens.   

Abstract

The Boyden chamber assay is widely used for in vitro measurement of the invasive capacity of cells. However, results can be affected significantly if certain precautions are not taken. Using the Boyden chamber assay we investigated in vitro the invasive potential of a variety of human gynecological tumor cell lines to degrade and migrate through the artificial basement membrane matrix Matrigel. However, in the absence of this Matrigel layer large differences were observed in the ability of cells to adhere to, migrate through and attach to the lower side of the filter membranes. These differences were influenced by cell density, degree of directional locomotion, and the size of the filter pores. To adjust for these influences (which are not directly correlated to the capacity of cells to traverse the Matrigel layer), invasion results were corrected for the ability of cells to migrate through the filter membrane. In addition, the invasion of MDA-MB-231 cells was used as an internal standard to compensate for variations in the Matrigel layer between different experiments. Overall, in our experimental set up, the five human breast cancer cell lines were the most invasive (mean invasion +/- SEM relative to MDA-MB-231 invasion: 104.7 +/- 6.1%), the five human ovarian cancer cell lines the least invasive (60.2 +/- 2.2%) and the six human endometrial cancer cell lines showed an intermediate capacity (79.1 +/- 3.5%). In conclusion, the Boyden chamber assay can be used reliably for studying the invasive potential of cells in vitro, if the ability of the cells to migrate through the filter is taken into account, and a reference cell line is included to enable comparison of the data obtained from independently performed experiments on different cell lines.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9009106     DOI: 10.1023/a:1018436407280

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  24 in total

1.  The promotion of invasion through the basement membrane of cervical carcinoma cells by fibronectin as a chemoattractant.

Authors:  K Sugihara; T Saito; M Okadome; K Sonoda; H Kobayashi; T Kamura; N Tsukamoto; H Nakano
Journal:  Cancer Lett       Date:  1994-05-16       Impact factor: 8.679

2.  Invasion of extracellular matrix by cultured colon cancer cells: dependence on urokinase receptor display.

Authors:  W Schlechte; M Brattain; D Boyd
Journal:  Cancer Commun       Date:  1990

3.  Inhibition of invasion, gelatinase activity, tumor take and metastasis of malignant cells by N-acetylcysteine.

Authors:  A Albini; F D'Agostini; D Giunciuglio; I Paglieri; R Balansky; S De Flora
Journal:  Int J Cancer       Date:  1995-03-29       Impact factor: 7.396

4.  Messenger RNA for urokinase plasminogen activator is expressed in myofibroblasts adjacent to cancer cells in human breast cancer.

Authors:  B S Nielsen; M Sehested; S Timshel; C Pyke; K Danø
Journal:  Lab Invest       Date:  1996-01       Impact factor: 5.662

5.  The invasive and metastatic properties of hormone-independent but hormone-responsive variants of MCF-7 human breast cancer cells.

Authors:  E W Thompson; N Brünner; J Torri; M D Johnson; V Boulay; A Wright; M E Lippman; P S Steeg; R Clarke
Journal:  Clin Exp Metastasis       Date:  1993-01       Impact factor: 5.150

6.  Prevention of metastasis by inhibition of the urokinase receptor.

Authors:  C W Crowley; R L Cohen; B K Lucas; G Liu; M A Shuman; A D Levinson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

7.  Modulation of plasminogen activator systems by matrix components in two breast cancer cell lines: MCF-7 and MDA-MB-231.

Authors:  N Pourreau-Schneider; P Delori; B Boutière; D Arnoux; F George; J Sampol; P M Martin
Journal:  J Natl Cancer Inst       Date:  1989-02-15       Impact factor: 13.506

8.  An experimental model for ovarian tumor invasion of cultured mesothelial cell monolayer.

Authors:  M Sawada; J Shii; H Akedo; O Tanizawa
Journal:  Lab Invest       Date:  1994-03       Impact factor: 5.662

9.  Evaluation of in vitro reconstituted basement membrane assay to assess the invasiveness of tumor cells.

Authors:  N Simon; A Noël; J M Foidart
Journal:  Invasion Metastasis       Date:  1992

10.  In vivo and in vitro invasion in relation to phenotypic characteristics of human colorectal carcinoma cells.

Authors:  J E de Vries; W N Dinjens; G K De Bruyne; H W Verspaget; E P van der Linden; A P de Bruïne; M M Mareel; F T Bosman; J ten Kate
Journal:  Br J Cancer       Date:  1995-02       Impact factor: 7.640

View more
  14 in total

1.  A modified Boyden chamber assay for tumor cell transendothelial migration in vitro.

Authors:  Y H Li; C Zhu
Journal:  Clin Exp Metastasis       Date:  1999-07       Impact factor: 5.150

2.  Identification of BCAR3 by a random search for genes involved in antiestrogen resistance of human breast cancer cells.

Authors:  T van Agthoven; T L van Agthoven; A Dekker; P J van der Spek; L Vreede; L C Dorssers
Journal:  EMBO J       Date:  1998-05-15       Impact factor: 11.598

3.  Quantitative method for in vitro matrigel invasiveness measurement through image analysis software.

Authors:  Gabriel Gallo-Oller; Juan A Rey; Javier Dotor; Javier S Castresana
Journal:  Mol Biol Rep       Date:  2014-07-03       Impact factor: 2.316

4.  Characterizing breast cancer mouse xenografts with T₁ρ -MRI: a preliminary study.

Authors:  Lin Z Li; He N Xu; Ravinder Reddy
Journal:  Adv Exp Med Biol       Date:  2011       Impact factor: 2.622

5.  Quantitative mitochondrial redox imaging of breast cancer metastatic potential.

Authors:  He N Xu; Shoko Nioka; Jerry D Glickson; Britton Chance; Lin Z Li
Journal:  J Biomed Opt       Date:  2010 May-Jun       Impact factor: 3.170

6.  The brain slice chamber, a novel variation of the Boyden Chamber Assay, allows time-dependent quantification of glioma invasion into mammalian brain in vitro.

Authors:  Christian Schichor; Siglinde Kerkau; Theresa Visted; Rudolf Martini; Rolf Bjerkvig; Jörg Christian Tonn; Roland Goldbrunner
Journal:  J Neurooncol       Date:  2005-05       Impact factor: 4.130

7.  Modifications to the Transwell Migration/Invasion Assay Method That Eases Assay Performance and Improves the Accuracy.

Authors:  Heidi Marie Stoellinger; Arshak R Alexanian
Journal:  Assay Drug Dev Technol       Date:  2022-02-23       Impact factor: 1.738

8.  Dichloroacetate induces apoptosis in endometrial cancer cells.

Authors:  Jason Y Y Wong; Gordon S Huggins; Marcella Debidda; Nikhil C Munshi; Immaculata De Vivo
Journal:  Gynecol Oncol       Date:  2008-04-18       Impact factor: 5.482

9.  Differential role of gonadotropin-releasing hormone on human ovarian epithelial cancer cell invasion.

Authors:  Chien-Lin Chen; Lydia W T Cheung; Man-Tat Lau; Jung-Hye Choi; Nelly Auersperg; Hsin-Shih Wang; Alice S T Wong; Peter C K Leung
Journal:  Endocrine       Date:  2007-06       Impact factor: 3.633

10.  A comparative evaluation of various invasion assays testing colon carcinoma cell lines.

Authors:  N J de Both; M Vermey; W N Dinjens; F T Bosman
Journal:  Br J Cancer       Date:  1999-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.